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IMPACT OF XENOESTROGENS ON REPRODUCTIVE HEALTH
Abstract
Xenoestrogens such as phthalates, parabens, bisphenol A,
dichlorodiphenyltrichloroethane, and dioxins are compounds found in ordinary
substances such as detergents, cosmetics, plastics, pesticides and herbicides
(Sonnenschein & Soto, 1998). Estrogen is a vital component in the development of the
male and female reproductive system. However, xenoestrogens mimic endogenous
estrogenic signaling and exhibit endocrine disrupting properties that may cause longlasting repercussions on human reproductive health. Xenoestrogen bind to both
intracellular and membrane-bound estrogen receptors resulting in an inappropriate
activation of tissue-specific estrogenic responses, leading to low sperm count in males
and precocious puberty and polycystic ovarian syndrome in females (Shanle & Xu,
2011). Although the pathways of many xenoestrogens mechanism are unknown, the
detrimental outcomes on reproductive health are evident.

3

IMPACT OF XENOESTROGENS ON REPRODUCTIVE HEALTH

4

Impact of Xenoestrogens on Reproductive Health
Introduction
Xenoestrogens are endocrine disrupting chemicals that mimic estrogen in the
human body. Exposure to xenoestrogens have far reaching repercussions on human
reproductive health. Exposure to endocrine disrupting xenoestrogens alter the
homeostasis of the reproductive system. This paper will discuss the predominant
mechanisms of endocrine disruptors, the origins of xenoestrogens, the biological effects
of xenoestrogens on the human reproductive system, and methods to minimize
xenoestrogen exposure. Although a portion of the data incorporated in this paper will be
collected from primary research articles with non-human subjects, the chief conclusions
of this review will pertain to the human reproductive system (Takeuchi, Tsutsumi,
Ikezuki, Takai, & Taketani, 2004).
17−estradiol (E2) is the chief endogenous estrogen hormone. Estrogens such as
E2 are steroid hormones involved in a plethora of biological pathways such as the
formation of androstenedione which consequently regulate the physiology of many tissue
and organ functions including the development of both male and female reproductive
organs. (Yasar, Ayaz, User, Gupur, & Muyan, 2016). The effects of estrogens are
mediated through binding to the two estrogen receptors, estrogen receptor  (ER) and
estrogen receptor  (ER) Estrogen receptors largely behave as ligand specific
transcription factors. Xenoestrogens such as phthalates, bisphenol A (BPA), dioxins,
dichlorodiphenyltrichloroethane (DDT), and parabens mimic endogenous estrogen by
binding to ER and ER Like estrogen, xenoestrogens induce both genomic and non-
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genomic biological pathways. Repercussions of increased estrogen signaling through the
presence of xenoestrogens compounds on human reproductive health include an
increased frequency of precocious puberty and polycystic ovarian syndrome in females
(PCOS) and decreased sperm count in males.
Background and Significance
Further research regarding the effects of xenoestrogens is crucial due to a direct
correlation between the increased exposure to endocrine disrupting chemicals, the
declined sperm count in males, and the increased frequency of precocious puberty and
PCOS in females. Although general trends of the impact of xenoestrogens on
reproductive health are manifest, the understanding of the xenoestrogen mechanism is
insufficient (Jeung & Choi, 2010). Although there is a correlation between xenoestrogens
and carcinogenesis this will be excluded for purpose of clear focus in this paper.
Origins and Overview of Xenoestrogens
Estrogenic mimicking compounds are found in daily products such as pesticides,
industrial chemicals, cleaning products, and cosmetics (Sonnenschein & Soto, 1998).
Endocrine disrupting chemicals are defined as environmental and or dietary compounds
that interfere with endogenous hormone signaling, metabolism or synthesis (Shanle &
Xu, 2011). Xenoestrogens that bind to ERs by exhibiting estrogenic structural similarities
behave as endocrine disrupting compounds. Xenoestrogens alter biological functions
through the following predominant methods: mimicking endogenous estrogen, disrupting
synthesis and metabolism of endogenous estrogen and hormone receptors, and inhibiting
the binding of endogenous estrogen (Sonnenschein & Soto, 1998).
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Endocrine disrupting chemicals such as phthalate esters are frequently found in
plastics, detergents, solid waste disposal sites, and paints. Phthalates were first created in
1920, serving as an alternative plasticizer for camphor. In 1970, phthalates were banned;
however, their lasting effects are still prevalent (Wang et al., 2016). Studies have
confirmed that phthalates such as dibutyl phthalate, di-2-ethylhexyl phthalate, dimethyl
phthalate, monoethyl phthalate, mono-2-ethylhexyl phthalate, mono-benzyl phthalate,
and monobutyl phthalate have direct correlation to the decrease in sperm concentration,
motility, morphology, and DNA damage in humans (Wang et al., 2016).
Parabens such as methylparaben, ethylparaben, propylparaben, butylparaben, and
isobutylparaben are compounds commonly found in beauty and personal care products
such as shampoos, moisturizers, and face makeup. Parabens have anti-fungal and antibacterial properties and serve as common preservatives. Parabens were first
commercialized in the 1950’s and have continued to serve as preservatives in personal
care products throughout the years (Scientific American, 2014).
BPA was first synthesized in 1891 by German chemists. In 1950, during the
technology revolution, BPA production flourished alongside the growing plastic industry.
In 1953, polycarbonate resins from BPA were invented by Dr. Hermann Schnell.
Polycarbonate resins revolutionized the world of plastics, serving as a pliable yet durable
compound. Polycarbonates served as plastic components of electronic applications,
plastic bottles, and linings for metal-based cans. In the 1960’s the U.S. Food and Drug
Administration (FDA) approved polycarbonate resins for packaging of food (Caliendo,
2012).
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The estrogenic properties of BPA were not discovered until 1992 by Dr. David
Feldman. The discovery arose while autoclaving containers formed from polycarbonates
synthesized with BPA. The BPA leaching from the containers yielded estrogenic activity
(Rissman, 2016).
The structure of BPA provides the ability to bind to both the ER and R
receptor. As shown in Figure 1, the two (4,4’)-OH groups on the benzene rings allow
BPA to bind to the ER. BPA is classified as an endocrine disrupting compound that binds
to membrane-bound estrogen receptor inducing rapid non-genomic estrogenic signaling
(Shanle & Xu, 2011). Since its commercialization, BPA serves as a model for
xenoestrogen endocrine disrupting compounds. Industrially, BPA has been used as a
monomer in the production of epoxy resins and polycarbonates. These compounds are
common components of everyday products such as medical and dental devices, plastic
water bottles, and thermal paper. Humans can absorb BPA through external or internal
exposure. The highest exposure to BPA is attributed to food, resulting in part from plastic
irrigation apparatuses (Acconcia, Pallottini, & Marino, 2015).
The estrogen receptor affinity of BPA is notably lower than estradiol as shown in
Figure 2. However, the circulating concentrations of BPA can match, or exceed, the
circulating concentrations of estradiol. Humans can maintain an average of 1-2 ng/mL of
BPA circulating in serum and such concentrations are elevated enough to classify as a
biologically active level (Nagel & Bromfield, 2013). Such levels of circulating BPA have
been linked to a variety of reproductive-targeted pathologies such as infertility and
recurrent pregnancy loss (Acconcia et al., 2015).
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Figure 1. Chemical structure comparison between 17 -estradiol and Bisphenol A. The
ability of BPA to mimic estradiol derives structural similarities between the two phenol
groups of BPA and E2 (Steinmetz, Brown, Allen, Bigsby, & Ben-Jonathan, 1997). BPA
surpasses the minimum chemical structural requirements for estrogenic activity of a 4OH group on the A-phenyl ring and a hydrophobic side group on the 2-position of the
propane. The two (4,4’)-OH groups on the benzene rings allows BPA to bind to the ER.
Adapted from ACD/Structure Elucidator, C40E41, Advanced Chemistry Development,
Inc., 2017. Used by permission.
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Figure 2. Dose response curve of BPA versus E2. This dose response curve depicts BPA
eliciting an estrogenic response at high concentrations. This graph displays the
comparable binding trends of BPA to estrogen, supporting the estrogenic properties of
BPA. Used by permission from Dr. Cameron Q. Sheeler, Liberty University.

BPA disrupts the endocrine balance in the following three ways: estrogen
mimicking, antiandrogen behavior, and steroid hormone synthesis alteration. First, BPA
behaves as a xenoestrogen and binds to estrogen receptors causing estrogen-like
behaviors. Additionally, BPA behaves as an antiandrogen; blocking the standard action
of androgens. Through scientific studies of Acconcia, Pallottini and Marino (2015)
evaluating the antiandrogen behavior of BPA through transcriptional activation and
androgen receptor redistribution assay, it is known that BPA binds to androgen receptors,
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blocking nuclear translocation. BPA binds to androgen receptors in a manner that inhibits
the efficient transfer of the androgen receptor into the nucleus. When BPA is present, a
higher concentration of androgen receptors is required and or require a longer amount of
time for the translocation process to occur. Consequently, in the presence of BPA,
androgen receptor translocation is drastically delayed. Lastly, BPA has ability to alter the
synthesis of steroid hormones (Acconcia et al., 2015). BPA alters progesterone and
estradiol synthesis in vitro and reduces mRNA and protein expression levels of three
genes encoding steroidogenesis enzymes.
Dichlorodiphenyltrichloroethane (DDT) was once employed as a pesticide in
agricultural communities. DDT was first created in the United States during the 1940’s. It
quickly dominated the insecticide community due to its ability to combat insect-borne
human diseases such as malaria and typhus. In 1972, the use of DDT was banned in the
United States due to its adverse environmental effects (United States Environmental
Protection Agency, 2017).
DDT functions as an endocrine disrupting chemical through the following two
mechanisms: competing with endogenous estrogen for receptor binding sites and
stimulating the release of gonadotropin-releasing hormone (GnRH). Both functions cause
a notable disturbance to the homeostatic status of the human endocrine system. Due to
the stimulation of GnRH release, the presence of DDT can induce premature female
puberty. While DDT has not been shown to affect the male puberty process, exposure to
DDT post-puberty is linked to low semen quality (Nabi, Muhammad, Khan, & Ali,
2015).
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Dioxin behaves as another endocrine disrupting compound. Dioxins were first
produced in Germany in the 1800’s. In the early 1900’s dioxins were widely used in
electrical transformer cooling fluids, lubricants, and plastics. Due to the toxic properties
of dioxins, the United States Congress banned the use of dioxins in 1978. However,
dioxins are deemed a persistent environmental pollutant. Although widespread
throughout the environment, dioxins are commonly found in the food chain, specifically
the fatty tissue of animals. These harmful chemicals are both byproducts of a variety of
industrial processes such as chlorine bleaching and pesticide synthesis as well as natural
processes such as forest fires and volcanic eruptions (“Dioxins and Their Effect,” 2016).
Exposure to low concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin is associated with
the premature maturation of the genitals, gonads, and hypothalamic-pituitary axis (Nabi
et al., 2015).
Mechanism of Endocrine Disruptors
Xenoestrogens are classified as endocrine disrupting chemicals. The presence of
xenoestrogens may cause dysregulation of the estrogen receptor dependent transcriptional
pathways resulting in the false induction of tissue-specific estrogenic responses (Ozen &
Darcan, 2011). The inappropriate signaling resulting from xenoestrogen-estrogen receptor
binding can lead to the overall degradation of reproductive health, consequently altering
fertility (Shanle & Xu, 2011).
ER and ER serve as the two subtypes of nuclear estrogen receptors in humans
that mediate the effects of normal estrogen signaling in both reproductive and nonreproductive tissue (Shanle & Xu, 2011). Estrogen receptor subtype expressions show
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specificity to tissue types. In females, ER is highly expressed in reproductive tissues
such as the ovaries, uterus, and mammary glands. ER is minimally expressed in the
mammary glands while significantly expressed in the ovaries. In males, ER is highly
expressed in the prostate, epididymis, and germinal cells (Lecomte, Demay, Ferriere, &
Pakdel, 2017).
ER and ER function as ligand-dependent transcriptional factors; however,
ER and ER exhibit differing ligand specificities and transcriptional activities (Hess et
al., 1997). The function of ER and ER is dependent on cofactor availability and
cellular context (Shanle & Xu, 2011).
ER and ER are located respectively on chromosome 6 ESR1 and chromosome
14 ESR2 (Rochira et al., 2016). As denoted in Figure 3, ER is comprised of 595 amino
acids and includes eight exons, resulting in a total length of 66kDa proteins. The genomic
segment of ER spans approximately 300kb. ER is comprised of eight exons and 530
amino acids, spanning 254kb. The central domain of the estrogen receptors contains a
conserved zinc finger DNA-binding domain (Yasar et al., 2016). The ligand-independent
transactivation function is located on the N-terminal domain of the estrogen receptor
while the ligand-dependent transactivation function is located on the C-terminal domain
(Lecomte et al., 2017). The DNA binding domains exhibit a 97% similarity between both
ER and ER while the N-terminal and C-terminal exhibits a 17% and 56% similarity,
respectively (Yasar et al., 2016).
Xenoestrogens with endocrine disrupting activities must bind to intracellular or
membrane-bound estrogen receptors, activating a hormonal transduction system
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Figure 3. ER and ER are composed of 595 and 530 amino acids, respectively. Both
ER and ER are comprised of 8 exons. The N-terminal of ER and ER share an amino
acid similarity of 17% while the DNA binding region of central C exhibit a shared
identity of 97% of amino acids. Upon binding of E2, ER and ER dimerizes which
causes a conformational change resulting in a functionally active estrogen receptor.
Adapted from “Molecular mechanism of estrogen-estrogen receptor signaling.” By P.
Yasar, G. Ayaz, S. D. User, G. Gupur, and M. Muyan, 2017, Reproductive Medicine and
Biology, 16, p. 5. Copyright 2016 by Reproductive Medicine and Biology. Used by
permission.

(Welshons et al., 2003). Typically, xenoestrogens bind to intracellular estrogen receptors
acting on the genomic level. However, ER targeting xenoestrogens exhibit the potential to
alter both genomic and non-genomic estrogen receptor activity. Genomic altering
xenoestrogens include phytoestrogens, bisphenols, and organochlorine pesticides (Shanle
& Xu, 2011).
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As shown in Figures 4 and 5, genomic signaling results from ligands binding to
intracellular ER causing dimerization. Sequentially, ER dimers coupled with other
transcriptional factors directly bind to DNA, initiating a genomic transcription. The
intracellular ligand-dependent receptor process is contrasted with the non-genomic
process. The non-genomic process results from a ligand binding to membrane-bound
ERs, triggering a cellular cascade (Nadal et al., 2000). When ligands bind to membrane
bound ERs a rapid response to estrogenic exposure occurs (Shanle & Xu, 2011). As
depicted in Figure 5, the activity of membrane bound ERs is mediated through a Gprotein coupled receptor. This G-coupled protein receptor, known as GPR30, activates
MAPK or P13 kinase signaling cascade.
Another method of endocrine disrupting chemicals is through binding site
competition. Ligands bind to receptor sites through the amino acid side groups that
provide hydrophilic interactions or hydrogen bonding between ligand and receptor.
ER and ER contain large binding sites which allow the binding of a variety of small
molecules. The presence of high concentrations of endocrine disrupting chemicals with
affinity for ER and ER ligand binding sites minimizes the chance of the proper binding
of endogenous estrogen. An inappropriate activation of estrogen receptors results through
the binding of endocrine disrupting chemicals such as BPA (Shanle & Xu, 2011).
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Figure 4. Genomic versus non-genomic estrogen receptor signaling pathway. Genomic
signaling occurs when ligands, including xenoestrogens, diffuse across the cellular
phospholipid bilayer binding directly to the intracellular ER causing ER dimerization.
Dimerized ERs bind directly to the estrogen response element. Non-genomic signaling
occurs when ligands bind membrane-bound estrogen receptors resulting in activation of
kinase signaling cascade. Adapted from “Endocrine disrupting chemicals targeting
estrogen receptor signaling: identification and mechanisms of action.” By E. K. Shanle,
and W. Xu, 2011, Chemical Research in Toxicology, 14, p. 27. Used by permission.
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Figure 5. Integrated model of the activation of the kinase cascade leading to the cellular
response. The ER bound with E2 interacts with the G protein that activates kinases. The
kinases then phosphorylate regulatory proteins and transcriptional proteins leading to
alterations in gene expression. Adapted from “Molecular mechanism of estrogen-estrogen
receptor signaling.” By P. Yasar, G. Ayaz, S. D. User, G. Gupur, and M. Muyan, 2017,
Reproductive Medicine and Biology, 16, p. 9. Copyright 2016 by Reproductive Medicine
and Biology. Used by permission.
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Function of Endogenous Estrogen in the Female Reproductive System
Estrogen is an endogenous hormone that is vital in both males and females.
Estrogen regulates the development of secondary sexual characteristics such as the
regulation of menstrual cycle, stimulation of endometrium growth, and breast
development. In males, estrogen functions as a component in sperm maturation. Estrogen
serves as a feminizing factor during fetal development.
In female humans, endogenous estrogen is chiefly produced in the ovaries,
placenta, and adrenal glands. Through the action of androgenase, androgen, the estrogen
precursor, is converted to estrogen. The ovaries serve as the main site of estrogen
synthesis due to their high content of aromatase (Knudtson & McLaughlin, n.d.).
Estrogen is a primary regulator in the growth and development of the mammary
glands, vagina, fallopian tubes, uterus, egg follicle, and endometrial lining.
Estrogen circulates the bloodstream, targeting organs such as the breasts, vagina, and
uterus. As shown in Figure 6, puberty is initiated through the elevation of luteinizing
hormone (LH) and follicle-stimulating hormone (FSH) levels. This occurs as a result of
the release of GnRH by the hypothalamus. The increased release of GnRH results in LH
and FSH secretion. These high levels of LH and FSH promote the production of estrogen.
Elevated estrogen levels then result in the development of secondary sexual
characteristics (Knudtson & McLaughlin, n.d.)

IMPACT OF XENOESTROGENS ON REPRODUCTIVE HEALTH

18

Figure 6. Endocrinology of female reproductive system development. The hypothalamus
secretes gonadotropin-releasing hormone (GnRH) which regulates the release of the
luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior
pituitary gland. The ovaries are stimulated by LH and FSH and estrogen is synthesized.
Adapted from, “Hormonal Regulation of the Female Reproductive System.” 2017. Open
University. Used by permission.
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Effects of Xenoestrogens on the Female Reproductive System
Estrogen stimulates the generation of secondary female sexual characteristics
such as endometrial growth, menstrual cycle regulation, and breast development.
Puberty is characterized by the maturation of the hypothalamic pituitary gonadal axis in
addition to the development of secondary sexual features. The age at which puberty
occurs in females is growing progressively younger (Ozen & Darcan, 2001). Negative
health implications such as a predisposition to polycystic ovarian syndrome arises from
precocious puberty. The onset of puberty is regulated by the endocrine system and
exposure to xenoestrogens may have a dysregulating impact upon the hypothalamicpituitary-gonadal system (Massart et al., 2006).
Endocrine disruptors such as phytoestrogens and phthalates have been identified
as possible environmental factors influencing the onset of female puberty (Nabi et al.,
2015). Xenoestrogens directly influence the gonadotropin-releasing hormone resulting in
an increased endogenous estrogen production. Studies show that some xenoestrogens
cause premature puberty due to an activation of increased GnRH production. The release
of the GnRH from the hypothalamus causes the secretion of the follicle stimulating
hormone and luteinizing hormone which cause the progression of puberty. The
modification of normal GnRH release through the interference with xenoestrogens
directly impacts the progress of puberty (Ozen & Darcan, 2011).
These endocrine disrupting chemicals exert their estrogenic characteristics
through direct binding to intracellular or extracellular estrogen receptors or increasing
aromatase activity. Aromatase is an enzyme catalyst that increases the conversion of
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testosterone into estrogen. These behaviors increase the total amount of estrogenbehaving compounds present (Ozen & Darcan, 2011).
The female gonad exhibits heightened sensitivity to exposure to BPA. Endocrine
disrupting compounds such as BPA interfere with ovarian morphology, steroidogenesis,
and folliculogenesis. BPA, commonly found in ovarian follicular fluid, exhibits a
stimulatory role in ovarian theca-interstitial cells. These cells are responsible for the
production of androgens through the direct regulation of 17-hydroxylase. This
hydroxylase is a vital enzyme in androgen synthesis. Consequently, the presence of BPA
stimulates the production of androgen synthesis. Heightened androgen synthesis is a
characteristic of polycystic ovarian syndrome (Barrett & Sobolewski, 2014).
There is a strong correlation between polycystic ovarian syndrome (PCOS) and
BPA exposure. PCOS is defined by anovulation and hyperandrogenemia (Barrett &
Soboleweski, 2014). PCOS is responsible for 80% of anovulatory infertility cases (Melo,
Ferriani & Navarro, 2015). Scientific studies evaluating the BPA-serum levels of women
suffering from PCOS exhibited high levels of BPA compared to non-hyperandrogenemia
women (Takeuchi et al., 2004).
Effects of Estrogen on Male Reproductive Development
While testosterone serves as the hormone responsible for the development of
secondary male sexual characteristics, estrogen is a vital component of sperm maturation
and vitality. Blood-estrogen concentration in males is low; however, estrogen content in
semen and rete teste fluid is extraordinarily high, reaching up to 250 pg ml-1 (Ruz et al.,
2006). The two primary estrogen receptors, ER and ER, are present in the testes
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(Joseph et al., 2011). ER is expressed in fetal testes, suggesting a role of estrogen in the
maturation of testes (Rochira et al., 2016). Secondly, ER is expressed in the efferent
ductules regulating fluid reabsorption (Joseph et al., 2011).
Appropriate fluid regulation is an essential component in the male reproductive
system. The efferent ductules located in the testes serve as the primary site of fluid
reabsorption. ER serves as a fluid reabsorption regulator in the efferent ductules. Fluid
regulation includes the dictation of ion transport and water reabsorption (Joseph et al.,
2011).
Effects of Xenoestrogens on the Male Reproductive System
The detrimental effect of xenoestrogens on the male reproductive system is
chiefly via the manifestation of embryonic exposure to xenoestrogens. Such exposures
impact specific structures of the male reproductive system; ultimately, negatively
influencing future fertility (Rochira et al., 2016). Sperm counts in Western countries have
declined 50% since 1966. Sperm counts are also reported to have decreased from 113
million/mL to 66.5 million/mL from 1940 to 1990 (Giwercman, Carlsen, Keiding, &
Skakkebaek, 1993). This trend in decreasing sperm count has been partially credited to
the increase of endocrine disrupting xenoestrogens (Wang et al., 2016).
The impact of xenoestrogens on male fertility was first observed in wild animals
including fish, amphibians, mammals, reptiles, and birds that had exposure to estrogenic
chemicals in their natural environment. Alterations in male reproductive habits and the
general feminization in reproductive behavior have been noted in such wild animals
(Delbes, Levacher, & Habert, 2006).

IMPACT OF XENOESTROGENS ON REPRODUCTIVE HEALTH

22

Neonatal tests have proven to be highly sensitive to xenoestrogens. High exposure
to xenoestrogens correlates with the inactivation of ER and ER (Delbes et al., 2006).
Inactivation of ER and ER poses a serious threat to male fertility. Decreased fluid
reabsorption results in a backflow of fluid from the efferent ductules into the testes;
causing decreased sperm concentration and motility (Ruz et al., 2006). In addition to the
backflow of fluid into the testes, disruption of fluid levels results in diluted sperm
entering the epididymis decreasing sperm count in semen and ultimately decreasing
fertility (Hess et al., 1997). The ER role in fluid reabsorption has been tested through
mice with an ER knockout gene. Mice deficient of the estrogen receptor ER were
sterile due to the elevated fluid retention in the efferent ductules (Hess et al., 1997).
The absence, or diminished, levels of R are also linked to long-term teste
atrophy. Decreased fluid reabsorption stems from the lack of an epithelial cell component
responsible for the uptake of fluids. Such structures are the endocytic vesicles and PAS+
lysosomal granules of the epithelial cell. The backpressure resulting from luminal fluids
causes long-term atrophy of the testes (Hess et al., 1997).
Minimizing Xenoestrogen Exposure
The presence of endocrine disrupting chemicals in everyday household products
should not be minimized or dismissed. Xenoestrogens such as phthalates, BPA, and
parabens are found in perfumes, plastic containers, and cosmetics, respectively. Measures
can be taken to minimize the presence of xenoestrogen in one’s environment. Plastic
containers such as reusable plastic water bottles and food storage containers commonly
contain BPA products. Reheating food in plastic containers allows for heightened
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amounts of xenoestrogens to leach out and penetrate food. Avoiding consuming products
stored in plastics can be accomplished through drinking water from stainless steel water
bottles and alternatively using glass containers as a replacement for plasticware.
Cosmetic products and perfumes commonly contain endocrine disrupting
compounds such as phthalates. Phthalates can be found in personal care products items
including soaps, perfumes, nail polish removal, diaper cream, wet wipes, face paint, baby
powder, glitter gel, and baby oil (U.S. Food & Drug Administration [FDA], 2013).
The most predominant phthalate compounds historically found in personal care products
are dibutylpthalate, dimethlpthalate, and diethylphthalate. Today, diethylphthalate is the
primary phthalate still found in cosmetics (FDA, 2013). Exposure to phthalates can be
accomplished through the following mechanisms: ingestion, inhalation, integumentary
absorption, and intravenous injection. Industries use phthalates for solvent and fixative
properties of the compounds (Al-Saleh & Elkhatib, 2016). The FDA (2013) advises the
primary method of avoiding phthalates exposure from personal care products is to
consciously seek and buy non-phthalate containing products.
Parabens are compounds found in a wide variety of cosmetics such as shampoos,
moisturizers, shaving products, and deodorants. Parabens serve as anti-bacterial
compounds that prevent unwanted bacterial presence in personal care products. Despite
the beneficial presence of parabens regarding limiting bacterial growth, parabens exhibit
endocrine disrupting qualities. Exposure to parabens through personal care products can
be circumvented by prudently reading product labels. If a product contains parabens, the
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ingredient list would contain compound names such as methylparaben, propylparaben,
butylparaben, or ethylparaben (FDA, 2018).
Conclusion
Xenoestrogens are endocrine disrupting chemicals that mimic endogenous
estrogen in the human body. Chemicals such as PBA, parabens, phthalates, dioxins, and
dichlorodiphenyltrichloroethane are compounds found in pesticides, plastic containers,
and personal care products (Sonnenschein & Soto, 1998). Through mimicking estrogen,
xenoestrogens inappropriately trigger estrogen receptors. Xenoestrogens exhibit the
capabilities to trigger both genomic and non-genomic pathways through binding to
intracellular estrogen receptors and membrane-bound receptors, respectively.
Xenoestrogens alter biological functions through mimicking endogenous
estrogens, disrupting synthesis and metabolism of endogenous estrogen and hormone
receptors, and inhibiting the binding of endogenous estrogen (Sonnenschein & Soto,
1998). Exposure to such compounds have far reaching repercussions on human
reproductive health such as decreased sperm count, precocious puberty, and polycystic
ovarian syndrome. Xenoestrogen exposure can be minimized through implementing
lifestyle changes such as avoiding heating food in reusable plasticware and switching to
paraben-free health and beauty products.
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